Наблюдавано е значимо подобрение и на трите първични променливи: процентна промяна на общата честота
A significant improvement was observed for all three primary variables: the percentage change in total seizure frequency per 28 days during the maintenance phase relative to baseline (-35.8% on Inovelon vs. – 1.6% on placebo, p= 0.0006), the number of tonic-atonic seizures (-42.9% on Inovelon vs.